Exclusive License Acquired for Rapid Pathogen Identification Technology, to be Supported by SORCERER Platform

As part of our growth plan, we are expanding Proteomics into Microbiology. We recently signed an exclusive agreement with the U.S. Army Edgewood Chemical and Biological Center (ECBC).

This license allows for the integration of the ECBC Agents of Biological Origins Identification (ABOID) system into our existing SORCERER ™ proteomics platform, enabling rapid and cost-effective detection and identification of microorganisms.

ABOID is a broad-based technology that is well-known for its role in studying the honeybee Colony Collapse Disorder. However, it has reported success in rapid identification of pathogens in human infections, food-borne illness, and other fields.

Read More Here:
http://www.ecbc.army.mil/news/Patent_Licensing_Agreement_signed_at_ECBC.html

More News